Alaunos Therapeutics, Inc. Tax Credit Carryforward, Amount
Alaunos Therapeutics, Inc. (TCRT) had Tax Credit Carryforward, Amount of $0 as of 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2026-03-31
- 2024-12-31: Tax Credit Carryforward, Amount $0.00.
- 2023-12-31: Tax Credit Carryforward, Amount $0.00.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |